Semi-Annual Statement Of Income And Retained Earnings

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7555731

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
6,707,000,000 JPY
7,998,000,000 JPY
8,365,000,000 JPY
JPY
7,998,000,000 JPY
1,290,000,000 JPY
15,710,000,000 JPY
17,429,000,000 JPY
17,064,000,000 JPY
JPY
17,064,000,000 JPY
1,353,000,000 JPY
Non-operating income
Non-operating income
616,000,000 JPY
780,000,000 JPY
502,000,000 JPY
543,000,000 JPY
Non-operating expenses
Non-operating expenses
51,000,000 JPY
51,000,000 JPY
66,000,000 JPY
66,000,000 JPY
Ordinary profit (loss)
8,930,000,000 JPY
8,727,000,000 JPY
17,866,000,000 JPY
17,542,000,000 JPY
Extraordinary income
Extraordinary income
4,000,000 JPY
4,000,000 JPY
197,000,000 JPY
197,000,000 JPY
Extraordinary losses
Extraordinary losses
354,000,000 JPY
1,914,000,000 JPY
3,854,000,000 JPY
3,854,000,000 JPY
Profit (loss) before income taxes
8,580,000,000 JPY
6,817,000,000 JPY
14,209,000,000 JPY
13,885,000,000 JPY
Income taxes - current
3,980,000,000 JPY
3,998,000,000 JPY
4,487,000,000 JPY
4,513,000,000 JPY
Income taxes - deferred
-2,165,000,000 JPY
-2,621,000,000 JPY
-175,000,000 JPY
-177,000,000 JPY
Profit (loss)
6,765,000,000 JPY
6,765,000,000 JPY
6,765,000,000 JPY
6,765,000,000 JPY
5,440,000,000 JPY
9,897,000,000 JPY
9,897,000,000 JPY
9,897,000,000 JPY
9,897,000,000 JPY
9,549,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.